An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers
NCT00918606
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Subcutaneous Adipose Tissue Reduction
Interventions
DRUG:
LIPO-102
Sponsor
Neothetics, Inc